Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Lung
Erschienen in: Lung 2/2013

01.04.2013

Management of Malignant Pleural Effusion

verfasst von: Jack A. Kastelik

Erschienen in: Lung | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Malignancy is one of the most common causes of pleural effusion. Malignant pleural effusion is defined by the presence of malignant cells in the pleural fluid. Development of malignant pleural effusion usually defines advanced malignancy. Pathophysiology of malignant pleural effusion is not fully understood and may involve complex interactions between the mesothelial and malignant cells. Investigations and management of patients with malignant pleural effusion require a multidisciplinary approach. In this review, current practice for management of patients with malignant pleural effusion will be discussed. In addition, imaging techniques will be covered, including the use of thoracic ultrasound and its role in image-guiding pleural procedures. Moreover, interventional techniques will be described, such as medical thoracoscopy, the use of indwelling pleural catheters, or surgery for investigation and management of malignant pleural effusion.
Literatur
1.
2.
Bennett R, Maskell N (2005) Management of malignant pleural effusions. Curr Opin Pulm Med 11(4):296–300PubMed
3.
Shaw P, Agarwal R (2005) Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev (1):CD002916
4.
Heffner JE (2010) Management of the patient with a malignant pleural effusion. Semin Respir Crit Care Med 31(6):723–733PubMedCrossRef
5.
Awasthi A, Gupta N, Srinivasan R, Nijhawan R, Rajwanshi A (2007) Cytopathological spectrum of unusual malignant pleural effusions at a tertiary care centre in north India. Cytopathology 18(1):28–32PubMedCrossRef
6.
Heffner JE (2008) Diagnosis and management of malignant pleural effusions. Respirology 13(1):5–20PubMed
7.
Heffner JE, Klein JS (2008) Recent advances in the diagnosis and management of malignant pleural effusions. Mayo Clin Proc 83(2):235–250PubMed
8.
Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ (2010) Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax 65(Suppl 2):ii32–ii40PubMedCrossRef
9.
Burrows CM, Mathews WC, Colt HG (2000) Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease. Chest 117(1):73–78PubMedCrossRef
10.
Fernandez C, Martin C, Aranda I, Romero S (2000) Malignant transient pleural transudate: a sign of early lymphatic tumoral obstruction. Respiration 67(3):333–336PubMedCrossRef
11.
Estenne M, Yernault JC, De Troyer A (1983) Mechanism of relief of dyspnea after thoracocentesis in patients with large pleural effusions. Am J Med 74(5):813–819PubMedCrossRef
12.
Judson MA, Sahn SA (1995) Pulmonary physiologic abnormalities caused by pleural disease. Semin Respir Respir Crit Care Med 16:346–353CrossRef
13.
Wang JS, Tseng CH (1995) Changes in pulmonary mechanics and gas exchange after thoracentesis on patients with inversion of a hemidiaphragm secondary to large pleural effusion. Chest 107(6):1610–1614PubMedCrossRef
14.
Light RW, Stansbury DW, Brown SE (1986) The relationship between pleural pressures and changes in pulmonary function after therapeutic thoracentesis. Am Rev Respir Dis 133(4):658–661PubMed
15.
Lee YC, Light RW, Musk AW (2000) Management of malignant pleural mesothelioma: a critical review. Curr Opin Pulm Med 6(4):267–274PubMedCrossRef
16.
Bech C, Sorensen JB (2008) Polyneuropathy in a patient with malignant pleural mesothelioma: a paraneoplastic syndrome. J Thorac Oncol 3(11):1359–1360PubMedCrossRef
17.
Kashyap AS, Kashyap S (2001) An elderly man with pleural effusion and abnormal behaviour. Postgrad Med J 77(908):407–413PubMedCrossRef
18.
Banayan S, Hot A, Janier M, Ninet J, Zurlinden O, Billotey C (2006) Malignant mesothelioma of the peritoneum as the cause of a paraneoplastic syndrome: detection by 18F-FDG PET. Eur J Nucl Med Mol Imaging 33(6):751PubMedCrossRef
19.
Perks WH, Crow JC, Green M (1978) Mesothelioma associated with the syndrome of inappropriate secretion of antidiuretic hormone. Am Rev Respir Dis 117(4):789–794PubMed
20.
Balduyck B, Lauwers P, Govaert K, Hendriks J, De Maeseneer M, Van Schil P (2006) Solitary fibrous tumor of the pleura with associated hypoglycemia: Doege–Potter syndrome: a case report. J Thorac Oncol 1(6):588–590PubMedCrossRef
21.
Beck JM (1998) Pleural disease in patients with acquired immune deficiency syndrome. Clin Chest Med 19(2):341–349PubMedCrossRef
22.
Afessa B (2000) Pleural effusion and pneumothorax in hospitalized patients with HIV infection: the Pulmonary Complications, ICU support, and Prognostic Factors of Hospitalized Patients with HIV (PIP) Study. Chest 117(4):1031–1037PubMedCrossRef
23.
Afessa B (2001) Pleural effusions and pneumothoraces in AIDS. Curr Opin Pulm Med 7(4):202–209PubMedCrossRef
24.
Porcel JM, Civit MC, Bielsa S, Light RW (2012) Contarini’s syndrome: bilateral pleural effusion, each side from different causes. J Hosp Med 7(2):164–165PubMedCrossRef
25.
Lawton F, Blackledge G, Johnson R (1985) Co-existent chylous and serous pleural effusions associated with ovarian cancer: a case report of Contarini’s syndrome. Eur J Surg Oncol 11(2):177–178PubMed
26.
Kutty CP, Varkey B (1978) “Contarini’s condition:” bilateral pleural effusions with markedly different characteristics. Chest 74(6):679–680PubMedCrossRef
27.
McGrath EE, Anderson PB (2011) Diagnosis of pleural effusion: a systematic approach. Am J Crit Care 20(2):119–127PubMedCrossRef
28.
Lee YC, Light RW (2004) Management of malignant pleural effusions. Respirology 9(2):148–156PubMedCrossRef
29.
Hooper C, Lee YC, Maskell N (2010) Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 65(Suppl 2):ii4–17PubMedCrossRef
30.
Koenig SJ, Narasimhan M, Mayo PH (2011) Thoracic ultrasonography for the pulmonary specialist. Chest 140(5):1332–1341PubMedCrossRef
31.
32.
Kastelik JA, Alhajji M, Faruqi S, Teoh R, Arnold AG (2009) Thoracic ultrasound: an important skill for respiratory physicians. Thorax 64(9):825–826PubMedCrossRef
33.
Qureshi NR, Rahman NM, Gleeson FV (2009) Thoracic ultrasound in the diagnosis of malignant pleural effusion. Thorax 64(2):139–143PubMedCrossRef
34.
Havelock T, Teoh R, Laws D, Gleeson F (2010) Pleural procedures and thoracic ultrasound: British Thoracic Society Pleural Disease Guideline 2010. Thorax 65(Suppl 2):ii61–ii76PubMedCrossRef
35.
Duncan DR, Morgenthaler TI, Ryu JH, Daniels CE (2009) Reducing iatrogenic risk in thoracentesis: establishing best practice via experiential training in a zero-risk environment. Chest 135(5):1315–1320PubMedCrossRef
36.
Barnes TW, Morgenthaler TI, Olson EJ, Hesley GK, Decker PA, Ryu JH (2005) Sonographically guided thoracentesis and rate of pneumothorax. J Clin Ultrasound 33(9):442–446PubMedCrossRef
37.
Seneff MG, Corwin RW, Gold LH, Irwin RS (1986) Complications associated with thoracocentesis. Chest 90(1):97–100PubMedCrossRef
38.
Jones PW, Moyers JP, Rogers JT, Rodriguez RM, Lee YC, Light RW (2003) Ultrasound-guided thoracentesis: is it a safer method? Chest 123(2):418–423PubMedCrossRef
39.
Wrightson JM, Helm EJ, Rahman NM, Gleeson FV, Davies RJ (2009) Pleural procedures and pleuroscopy. Respirology 14(6):796–807PubMedCrossRef
40.
Heidecker J, Huggins JT, Sahn SA, Doelken P (2006) Pathophysiology of pneumothorax following ultrasound-guided thoracentesis. Chest 130(4):1173–1184PubMedCrossRef
41.
Rahman NM, Singanayagam A, Davies HE, Wrightson JM, Mishra EK, Lee YC et al (2010) Diagnostic accuracy, safety and utilisation of respiratory physician-delivered thoracic ultrasound. Thorax 65(5):449–453PubMedCrossRef
42.
Hooper CE, Lee YC, Maskell NA (2010) Setting up a specialist pleural disease service. Respirology 15(7):1028–1036PubMedCrossRef
43.
Erasmus JJ, McAdams HP, Rossi SE, Goodman PC, Coleman RE, Patz EF (2010) FDG PET of pleural effusions in patients with non-small cell lung cancer. AJR Am J Roentgenol 175(1):245–249CrossRef
44.
Truong MT, Viswanathan C, Erasmus JJ (2011) Positron emission tomography/computed tomography in lung cancer staging, prognosis, and assessment of therapeutic response. J Thorac Imaging 26(2):132–146PubMedCrossRef
45.
46.
Genestreti G, Moretti A, Piciucchi S, Giovannini N, Galassi R, Scarpi E et al (2012) FDG PET/CT response evaluation in malignant pleural mesothelioma patients treated with talc pleurodesis and chemotherapy. J Cancer 3:241–245PubMedCrossRef
47.
Duranti L, Leo F, Pastorino U (2012) PET scan contribution in chest tumor management: a systematic review for thoracic surgeons. Tumori 98(2):175–184PubMed
48.
Helm EJ, Matin TN, Gleeson FV (2010) Imaging of the pleura. J Magn Reson Imaging 32(6):1275–1286PubMedCrossRef
49.
Leung AN, Muller NL, Miller RR (1990) CT in differential diagnosis of diffuse pleural disease. AJR Am J Roentgenol 154(3):487–492PubMedCrossRef
50.
Metintas M, Ucgun I, Elbek O, Erginel S, Metintas S, Kolsuz M et al (2002) Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases. Eur J Radiol 41(1):1–9PubMedCrossRef
51.
Evans AL, Gleeson FV (2004) Radiology in pleural disease: state of the art. Respirology 9(3):300–312PubMedCrossRef
52.
Falaschi F, Battolla L, Mascalchi M, Cioni R, Zampa V, Lencioni R et al (1996) Usefulness of MR signal intensity in distinguishing benign from malignant pleural disease. AJR Am J Roentgenol 166(4):963–968PubMedCrossRef
53.
54.
Rahman NM, Mishra EK, Davies HE, Davies RJ, Lee YC (2008) Clinically important factors influencing the diagnostic measurement of pleural fluid pH and glucose. Am J Respir Crit Care Med 178(5):483–490PubMedCrossRef
55.
Fahim A, Kastelik JA (2010) The utility of pleural amylase measurement in metastatic mucinous adenocarcinoma. J R Coll Physicians Edinb 40(2):119–120PubMedCrossRef
56.
Rodriguez-Panadero F, Lopez MJ (1989) Low glucose and pH levels in malignant pleural effusions. Diagnostic significance and prognostic value in respect to pleurodesis. Am Rev Respir Dis 139(3):663–667PubMed
57.
Rodriguez-Panadero F, Lopez-Mejias J (1989) Survival time of patients with pleural metastatic carcinoma predicted by glucose and pH studies. Chest 95(2):320–324PubMedCrossRef
58.
Martinez-Garcia MA, Cases-Viedma E, Cordero-Rodriguez PJ, Hidalgo-Ramirez M, Perpina-Tordera M, Sanchis-Moret F et al (2000) Diagnostic utility of eosinophils in the pleural fluid. Eur Respir J 15(1):166–169PubMedCrossRef
59.
Ferreiro L, San Jose E, Gonzalez-Barcala FJ, Alvarez-Dobano JM, Golpe A, Gude F et al (2011) Eosinophilic pleural effusion: incidence, etiology and prognostic significance. Arch Bronconeumol 47(10):504–509PubMedCrossRef
60.
Oba Y, Abu-Salah T (2012) The prevalence and diagnostic significance of eosinophilic pleural effusions: a meta-analysis and systematic review. Respiration 83(3):198–208PubMedCrossRef
61.
Husain AN, Colby TV, Ordonez NG, Krausz T, Borczuk A, Cagle PT et al (2009) Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 133(8):1317–1331PubMed
62.
Pinelli V, Laroumagne S, Sakr L, Marchetti GP, Tassi GF, Astoul P (2012) Pleural fluid cytological yield and visceral pleural invasion in patients with epithelioid malignant pleural mesothelioma. J Thorac Oncol 7(3):595–598PubMedCrossRef
63.
Agrawal V, Doelken P, Sahn SA (2008) Pleural fluid analysis in chylous pleural effusion. Chest 133(6):1436–1441PubMedCrossRef
64.
McGrath EE, Blades Z, Anderson PB (2010) Chylothorax: aetiology, diagnosis and therapeutic options. Respir Med 104(1):1–8PubMedCrossRef
65.
Huggins JT (2010) Chylothorax and cholesterol pleural effusion. Semin Respir Crit Care Med 31(6):743–750PubMedCrossRef
66.
Davies HE, Sadler RS, Bielsa S, Maskell NA, Rahman NM, Davies RJ et al (2009) Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions. Am J Respir Crit Care Med 180(5):437–444PubMedCrossRef
67.
Bielsa S, Esquerda A, Salud A, Montes A, Arellano E, Rodriguez-Panadero F et al (2009) High levels of tumor markers in pleural fluid correlate with poor survival in patients with adenocarcinomatous or squamous malignant effusions. Eur J Intern Med 20(4):383–386PubMedCrossRef
68.
Gaspar MJ, De Miguel J, Garcia Diaz JD, Diez M (2008) Clinical utility of a combination of tumour markers in the diagnosis of malignant pleural effusions. Anticancer Res 28(5B):2947–2952PubMed
69.
Creaney J, Robinson BW (2009) Serum and pleural fluid biomarkers for mesothelioma. Curr Opin Pulm Med 15(4):366–370PubMedCrossRef
70.
Creaney J, Francis RJ, Dick IM, Musk AW, Robinson BW, Byrne MJ et al (2011) Serum soluble mesothelin concentrations in malignant pleural mesothelioma: relationship to tumor volume, clinical stage and changes in tumor burden. Clin Cancer Res 17(5):1181–1189PubMedCrossRef
71.
Hollevoet K, Reitsma JB, Creaney J, Grigoriu BD, Robinson BW, Scherpereel A et al (2012) Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis. J Clin Oncol 30(13):1541–1549PubMedCrossRef
72.
Porcel JM, Esquerda A, Rodriguez-Panadero F, Martinez-Iribarren A, Bielsa S (2011) The use of pleural fluid sCD44v6/std ratio for distinguishing mesothelioma from other pleural malignancies. J Thorac Oncol 6(1):190–194PubMedCrossRef
73.
van der Bij S, Schaake E, Koffijberg H, Burgers JA, de Mol BA, Moons KG (2011) Markers for the non-invasive diagnosis of mesothelioma: a systematic review. Br J Cancer 104(8):1325–1333PubMedCrossRef
74.
Hooper CE, Elvers KT, Welsh GI, Millar AB, Maskell NA (2012) VEGF and sVEGFR-1 in malignant pleural effusions: association with survival and pleurodesis outcomes. Lung Cancer 77(2):443–449PubMedCrossRef
75.
Sriram KB, Relan V, Clarke BE, Duhig EE, Yang IA, Bowman RV et al (2011) Diagnostic molecular biomarkers for malignant pleural effusions. Future Oncol 7(6):737–752PubMedCrossRef
76.
Garcia LW, Ducatman BS, Wang HH (1994) The value of multiple fluid specimens in the cytological diagnosis of malignancy. Mod Pathol 7(6):665–668PubMed
77.
Swiderek J, Morcos S, Donthireddy V, Surapaneni R, Jackson-Thompson V, Schultz L et al (2010) Prospective study to determine the volume of pleural fluid required to diagnose malignancy. Chest 137(1):68–73PubMedCrossRef
78.
Dekker A, Bupp PA (1978) Cytology of serous effusions. An investigation into the usefulness of cell blocks versus smears. Am J Clin Pathol 70(6):855–860PubMed
79.
Nguyen KS, Neal JW (2012) First-line treatment of EGFR-mutant non-small-cell lung cancer: the role of erlotinib and other tyrosine kinase inhibitors. Biologics 6:337–344PubMed
80.
Gridelli C, Ciardiello F, Gallo C, Feld R, Butts C, Gebbia V et al (2012) First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial. J Clin Oncol 30(24):3002–3011PubMedCrossRef
81.
Salyer WR, Eggleston JC, Erozan YS (1975) Efficacy of pleural needle biopsy and pleural fluid cytopathology in the diagnosis of malignant neoplasm involving the pleura. Chest 67(5):536–539PubMedCrossRef
82.
Escudero BC, Garcia CM, Cuesta CB, Molinos ML, Rodriguez RS, Gonzalez PA et al (1990) Cytologic and bacteriologic analysis of fluid and pleural biopsy specimens with Cope’s needle. Study of 414 patients. Arch Intern Med 150(6):1190–1194CrossRef
83.
Frist B, Kahan AV, Koss LG (1979) Comparison of the diagnostic values of biopsies of the pleura and cytologic evaluation of pleural fluids. Am J Clin Pathol 72(1):48–51PubMed
84.
Chen NH, Hsieh IC, Tsao TC (1997) Comparison of the clinical diagnostic value between pleural needle biopsy and analysis of pleural effusion. Changgeng Yi Xue Za Zhi 20(1):11–16PubMed
85.
Prakash UB, Reiman HM (1985) Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases. Mayo Clin Proc 60(3):158–164PubMedCrossRef
86.
Von Hoff DD, LiVolsi V (1975) Diagnostic reliability of needle biopsy of the parietal pleura. A review of 272 biopsies. Am J Clin Pathol 64(2):200–203
87.
Salyer WR, Eggleston JC, Erozan YS (1980) Comparison of the diagnostic values of pleural biopsies and cytologic evaluation of pleural fluids. Am J Clin Pathol 73(2):289PubMed
88.
Maskell NA, Gleeson FV, Davies RJ (2003) Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial. Lancet 361(9366):1326–1330PubMedCrossRef
89.
Adams RF, Gray W, Davies RJ, Gleeson FV (2001) Percutaneous image-guided cutting needle biopsy of the pleura in the diagnosis of malignant mesothelioma. Chest 120(6):1798–1802PubMedCrossRef
90.
Rahman NM, Ali NJ, Brown G, Chapman SJ, Davies RJ, Downer NJ et al (2010) Local anaesthetic thoracoscopy: British Thoracic Society Pleural Disease Guideline 2010. Thorax 65(Suppl 2):ii54–ii60PubMedCrossRef
91.
92.
Rodriguez-Panadero F, Janssen JP, Astoul P (2006) Thoracoscopy: general overview and place in the diagnosis and management of pleural effusion. Eur Respir J 28(2):409–422PubMedCrossRef
93.
Yim AP, Izzat MB, Lee TW, Wan S (1999) Video-assisted thoracic surgery: a renaissance in surgical therapy. Respirology 4(1):1–8PubMedCrossRef
94.
Froudarakis ME, Noppen M (2009) Medical thoracoscopy: new tricks for an old trade. Respiration 78(4):373–374PubMedCrossRef
95.
96.
Munavvar M, Khan MA, Edwards J, Waqaruddin Z, Mills J (2007) The autoclavable semirigid thoracoscope: the way forward in pleural disease? Eur Respir J 29(3):571–574PubMedCrossRef
97.
Lee P, Hsu A, Lo C, Colt HG (2007) Prospective evaluation of flex-rigid pleuroscopy for indeterminate pleural effusion: accuracy, safety and outcome. Respirology 12(6):881–886PubMedCrossRef
98.
Tassi GF, Davies RJ, Noppen M (2006) Advanced techniques in medical thoracoscopy. Eur Respir J 28(5):1051–1059PubMedCrossRef
99.
Tassi GF, Marchetti GP, Aliprandi PL (2011) Advanced medical thoracoscopy. Monaldi Arch Chest Dis 75(1):99–101PubMed
100.
Tassi G, Marchetti G (2003) Minithoracoscopy: a less invasive approach to thoracoscopy. Chest 124(5):1975–1977PubMedCrossRef
101.
Greillier L, Cavailles A, Fraticelli A, Scherpereel A, Barlesi F, Tassi G et al (2007) Accuracy of pleural biopsy using thoracoscopy for the diagnosis of histologic subtype in patients with malignant pleural mesothelioma. Cancer 110(10):2248–2252PubMedCrossRef
102.
Kolschmann S, Ballin A, Gillissen A (2005) Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions. Chest 128(3):1431–1435PubMedCrossRef
103.
Gondker A, Pathmanathan S, Kastelik J (2011) Practical procedures: chemical pleurodesis—what is it & how to do it. Found Years J 5(9):88–92
104.
Rodriguez-Panadero F, Montes-Worboys A (2012) Mechanisms of pleurodesis. Respiration 83(2):91–98PubMedCrossRef
105.
Rodriguez-Panadero F, Segado A, Martin JJ, Ayerbe R, Torres GI, Castillo J (1995) Failure of talc pleurodesis is associated with increased pleural fibrinolysis. Am J Respir Crit Care Med 151(3 Pt 1):785–790PubMed
106.
Schwarz Y, Star A (2012) Role of talc modulation on cytokine activation in cancer patients undergoing pleurodesis. Pulm Med 2012:806183. Epub 2012 Mar 7
107.
Maskell NA, Lee YC, Gleeson FV, Hedley EL, Pengelly G, Davies RJ (2004) Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size. Am J Respir Crit Care Med 170(4):377–382PubMedCrossRef
108.
Fraticelli A, Robaglia-Schlupp A, Riera H, Monjanel-Mouterde S, Cau P, Astoul P (2002) Distribution of calibrated talc after intrapleural administration: an experimental study in rats. Chest 122(5):1737–1741PubMedCrossRef
109.
Maceachern P, Tremblay A (2011) Pleural controversy: pleurodesis versus indwelling pleural catheters for malignant effusions. Respirology 16(5):747–754PubMedCrossRef
110.
Davies HE, Mishra EK, Kahan BC, Wrightson JM, Stanton AE, Guhan A et al (2012) Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. JAMA 307(22):2383–2389PubMed
111.
Spiegler PA, Hurewitz AN, Groth ML (2003) Rapid pleurodesis for malignant pleural effusions. Chest 123(6):1895–1898PubMedCrossRef
112.
Goodman A, Davies CW (2006) Efficacy of short-term versus long-term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions: a randomised trial. Lung Cancer 54(1):51–55PubMedCrossRef
113.
Bielsa S, Hernandez P, Rodriguez-Panadero F, Taberner T, Salud A, Porcel JM (2011) Tumor type influences the effectiveness of pleurodesis in malignant effusions. Lung 189(2):151–155PubMedCrossRef
114.
Dresler CM, Olak J, Herndon JE, Richards WG, Scalzetti E, Fleishman SB et al (2005) Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest 127(3):909–915PubMedCrossRef
115.
Janssen JP, Collier G, Astoul P, Tassi GF, Noppen M, Rodriguez-Panadero F et al (2007) Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet 369(9572):1535–1539PubMedCrossRef
116.
Huggins JT, Sahn SA, Heidecker J, Ravenel JG, Doelken P (2007) Characteristics of trapped lung: pleural fluid analysis, manometry, and air-contrast chest CT. Chest 131(1):206–213PubMedCrossRef
117.
Puri V, Pyrdeck TL, Crabtree TD, Kreisel D, Krupnick AS, Colditz GA et al (2012) Treatment of malignant pleural effusion: a cost-effectiveness analysis. Ann Thorac Surg 94(2):374–380PubMedCrossRef
118.
Tremblay A, Mason C, Michaud G (2007) Use of tunnelled catheters for malignant pleural effusions in patients fit for pleurodesis. Eur Respir J 30(4):759–762PubMedCrossRef
119.
Tremblay A, Michaud G (2006) Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest 129(2):362–368PubMedCrossRef
120.
Bibby AC, Maskell NA (2011) Pleural procedures: intercostal chest drains and indwelling pleural catheters. Br J Hosp Med (Lond) 72(6):331–335
121.
Van Meter ME, McKee KY, Kohlwes RJ (2011) Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: a systematic review. J Gen Intern Med 26(1):70–76PubMedCrossRef
122.
Putnam JB Jr, Light RW, Rodriguez RM, Ponn R, Olak J, Pollak JS et al (1999) A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer 86(10):1992–1999PubMedCrossRef
123.
Demmy TL, Gu L, Burkhalter JE, Toloza EM, D’Amico TA, Sutherland S et al (2012) Optimal management of malignant pleural effusions (results of CALGB 30102). J Natl Compr Canc Netw 10(8):975–982PubMed
124.
Reddy C, Ernst A, Lamb C, Feller-Kopman D (2011) Rapid pleurodesis for malignant pleural effusions: a pilot study. Chest 139(6):1419–1423PubMedCrossRef
125.
Zarogoulidis P, Chatzaki E, Hohenforst-Schmidt W, Goldberg EP, Galaktidou G, Kontakiotis T et al (2012) Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review. Cancer Gene Ther 19(9):593–600PubMedCrossRef
126.
Morgensztern D, Waqar S, Subramanian J, Trinkaus K, Govindan R (2012) Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer. J Thorac Oncol 7(10):1485–1489PubMedCrossRef
127.
Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN (2007) Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol 608:1–22PubMedCrossRef
128.
Rastelli F, Crispino S (2008) Factors predictive of response to hormone therapy in breast cancer. Tumori 94(3):370–383PubMed
129.
Hind D, Ward S, De Nigris E, Simpson E, Carroll C, Wyld L (2007) Hormonal therapies for early breast cancer: systematic review and economic evaluation. Health Technol Assess 11(26):iii–xiPubMed
130.
El Saghir NS, Tfayli A, Hatoum HA, Nachef Z, Dinh P, Awada A (2011) Treatment of metastatic breast cancer: state-of-the-art, subtypes and perspectives. Crit Rev Oncol Hematol 80(3):433–449PubMedCrossRef
131.
Barton S, Swanton C (2011) Recent developments in treatment stratification for metastatic breast cancer. Drugs 71(16):2099–2113PubMedCrossRef
132.
Carey LA (2010) Directed therapy of subtypes of triple-negative breast cancer. Oncologist 15(Suppl 5):49–56PubMedCrossRef
133.
Santos GT, Prolla JC, Camillo ND, Zavalhia LS, Ranzi AD, Bica CG (2012) Clinical and pathological factors influencing the survival of breast cancer patients with malignant pleural effusion. J Bras Pneumol 38(4):487–493PubMedCrossRef
134.
Koo JS, Jung W, Jeong J (2010) Metastatic breast cancer shows different immunohistochemical phenotype according to metastatic site. Tumori 96(3):424–432PubMed
135.
Pokieser W, Cassik P, Fischer G, Vesely M, Ulrich W, Peters-Engl C (2004) Malignant pleural and pericardial effusion in invasive breast cancer: impact of the site of the primary tumor. Breast Cancer Res Treat 83(2):139–142PubMedCrossRef
136.
Kido H, Morizane C, Tamura T, Hagihara A, Kondo S, Ueno H et al (2012) Gemcitabine-induced pleuropericardial effusion in a patient with pancreatic cancer. Jpn J Clin Oncol 42(9):845–850PubMedCrossRef
137.
Whitworth JM, Schneider KE, Fauci JM, Bryant AS, Cerfolio RJ, Straughn JM Jr (2012) Outcomes of patients with gynecologic malignancies undergoing video-assisted thoracoscopic surgery (VATS) and pleurodesis for malignant pleural effusion. Gynecol Oncol 125(3):646–648PubMedCrossRef
138.
Hirata T, Yonemori K, Hirakawa A, Shimizu C, Tamura K, Ando M et al (2011) Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients. Eur Respir J 38(6):1425–1430PubMedCrossRef
139.
Treasure T, Sedrakyan A (2004) Pleural mesothelioma: little evidence, still time to do trials. Lancet 364(9440):1183–1185PubMedCrossRef
140.
van Ruth S, Baas P, Zoetmulder FA (2003) Surgical treatment of malignant pleural mesothelioma: a review. Chest 123(2):551–561PubMedCrossRef
141.
Bolukbas S, Manegold C, Eberlein M, Bergmann T, Fisseler-Eckhoff A, Schirren J (2011) Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with cisplatin/pemetrexed and radiotherapy. Lung Cancer 71(1):75–81PubMedCrossRef
142.
Flores RM (2009) Surgical options in malignant pleural mesothelioma: extrapleural pneumonectomy or pleurectomy/decortication. Semin Thorac Cardiovasc Surg 21(2):149–153PubMedCrossRef
143.
Zauderer MG, Krug LM (2011) The evolution of multimodality therapy for malignant pleural mesothelioma. Curr Treat Options Oncol 12(2):163–172PubMedCrossRef
144.
Treasure T, Lang-Lazdunski L, Waller D, Bliss JM, Tan C, Entwesle J, Snee M, O’Brien M, Thomas G et al (2011) Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol 2(8):763–772CrossRef
145.
Flores RM, Pass HI, Seshan VE, Dycoco J, Zakowski M, Carbone M et al (2008) Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 135(3):620–626PubMedCrossRef
146.
Kaifi JT, Toth JW, Gusani NJ, Kimchi ET, Staveley-O’Carroll KF, Belani CP et al (2012) Multidisciplinary management of malignant pleural effusion. J Surg Oncol 105(7):731–738PubMedCrossRef
147.
Morel A, Mishra E, Medley L, Rahman NM, Wrightson J, Talbot D et al (2011) Chemotherapy should not be withheld from patients with an indwelling pleural catheter for malignant pleural effusion. Thorax 66(5):448–449PubMedCrossRef
148.
Gompelmann D, Eberhardt R, Herth FJ (2011) Advanced malignant lung disease: what the specialist can offer. Respiration 82(2):111–123PubMedCrossRef
Metadaten
Titel
Management of Malignant Pleural Effusion
verfasst von
Jack A. Kastelik
Publikationsdatum
01.04.2013
Verlag
Springer-Verlag
Erschienen in
Lung / Ausgabe 2/2013
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-012-9445-1

Weitere Artikel der Ausgabe 2/2013

Lung 2/2013 Zur Ausgabe

ReviewPaper

Safety and Efficacy of 12-Week or Longer Indacaterol Treatment in Moderate-to-Severe COPD Patients: A Systematic Review

OriginalPaper

Dynamic Hyperinflation Correlates with Exertional Oxygen Desaturation in Patients with Chronic Obstructive Pulmonary Disease

OriginalPaper

Bronchial Responsiveness to Dry Air Hyperventilation in Smokers May Predict Decline in Airway Status Using Indirect Methods

OriginalPaper

A Possible Role of Galectin-9 in the Pulmonary Fibrosis of Patients with Interstitial Pneumonia

OriginalPaper

TGF-β1 T869C Polymorphism May Affect Susceptibility to Idiopathic Pulmonary Fibrosis and Disease Severity

OriginalPaper

Urokinase Receptor Orchestrates the Plasminogen System in Airway Epithelial Cell Function

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 | Hypertonie | Nachrichten

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 | Parkinson-Krankheit | Nachrichten

Viel Bewegung in der Parkinsonforschung

25.04.2024 | Nierenkarzinom | Nachrichten

Adjuvante Immuntherapie verlängert Leben bei RCC
weitere anzeigen

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise